Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Cape Breton Growth Fund (CBGF) was a Canadian federal Crown corporation established in 2000 to stimulate economic growth and diversification in Cape Breton, Nova Scotia. Operating as a subsidiary of the Enterprise Cape Breton Corporation (ECBC), the fund was tasked with providing financial support and venture capital to local businesses following the closure of the region's coal mines and steel plants. Although it invested in various sectors, including technology and manufacturing, it was an economic development vehicle rather than a life sciences or biotechnology firm. The corporation was officially wound down in the late 2000s, with its functions absorbed by the Atlantic Canada Opportunities Agency (ACOA).
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Cape Breton Growth Fund.